two new protease inhibitors for hepatitis C, Incivek (telaprevir) and Victrelis (boceprevir)
August 2011
You'll see two new protease inhibitors for hepatitis C, Incivek (telaprevir) and Victrelis (boceprevir).
That's right...protease inhibitors for hep C.
These are "game changers" because they offer a much higher cure rate when added to pegylated interferon and ribavirin for hep C. They can also shorten treatment duration.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote